TRSG Update on Product Sales.Business Editors LAS VEGAS--(BUSINESS WIRE)--Oct. 30, 2001 TRSG Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: TSGO) a majority-owned subsidiary majority-owned subsidiary A firm in which more than 50% of outstanding voting stock is owned by the parent company. of Gateway Distributors Ltd. (OTC BB: GTWY GTWY Gateway ), Tuesday announced that the sales of hand-held, low-cost devices used to detect the presence of biological agents have exceeded expectations. TRSG began sale of the units last week and within the last seven days have commitments for over 15,000 units. Orders will be filled on a first-come basis. The company is working with their manufactures to increase production to fill the demand. We currently have inventory in stock and are expecting our next order within five days. The company has finalized negotiations for licensing agreements with two individual companies to represent and sell some of our products and will make an announcement shortly regarding these companies. The company's new Biological Agent Detection Product utilizes UV-A UV-A or UVA Noun ultraviolet radiation with a range of 320-380 nanometres waves or waves in the 320 to 380 nm range, commonly referred to as black light or wood's light Wood's light n. Ultraviolet light produced by Wood's lamp. Wood's light, lamp ultraviolet radiation from a mercury vapor source, transmitted through a nickel oxide filter (Wood's filter), which holds back all but a few violet rays , that have been determined to not cause sunburn sunburn, inflammation of the skin caused by actinic rays from the sun or artificial sources. Moderate exposure to ultraviolet radiation is followed by a red blush, but severe exposure may result in blisters, pain, and constitutional symptoms. to human skin though the use of eye protection is recommended during use. These products are for detection purposes only and are not intended as a treatment or cure for any specific disease. Ongoing research is being conducted at this time to verify the product's effectiveness in the use of identifying the presence of a wide range of biological agents such as Becillus Anthraci, which is currently making headlines across the country. Independent research laboratories are conducting this research. Additional information regarding these studies can be found on the following Web sites: http://www.potomacinstitute.org/pubs/advtech.pdf http://www.potomacinstitute.org/press/transitpolicing.htm http://www.hhmi.org/grants/lectures/biointeractive/web_video/ hantavirus hantavirus, any of a genus (Hantavirus) of single-stranded RNA viruses that are carried by rodents and transmitted to humans when they inhale vapors from contaminated rodent urine, saliva, or feces. There are many strains of hantavirus. .htm http://www.cdc.gov/ncidod/dbmd/diseaseinfo/anthrax_g.htm TRSG Corp. ("TRSG" or "the company") believes that this product will enhance their current line of health food products. President Rick Bailey said, "We are extremely excited for all of our distributors and employees and thank them for all their hard work over the past year in helping build and promote the company." Additional information on our company can be found on our Web sites, which are as follows: www.rightsolution.com www.trsgcorp.com A number of statements contained in this press release are forward-looking statements which are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results that TRSG may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion